Zota Health Care Limited has submitted an investor presentation for the third quarter of the financial year 2026 (Q3FY26). The presentation was broadcast on February 5, 2026. The company highlights significant growth in its Davaindia store network, which expanded to 2,331 stores as of December 31, 2025, with an addition of 276 stores in Q3FY26. This growth contributed to a robust year-on-year top-line growth of 98%. However, operating profit and EBITDA saw a sequential decline primarily due to increased operating expenses for over 400 stores under development or in a non-live stage. Consequently, the company reported a consolidated operating loss of ₹44.11 lakhs and consolidated EBITDA of ₹127.58 lakhs. The company also announced the successful completion of a ₹350 crore Qualified Institutional Placement (QIP), which will strengthen its balance sheet and provide capital for accelerating COCO store rollouts, supporting working capital, and general corporate purposes. Zota Health Care remains confident in its long-term ambition to exceed 5,000 Davaindia stores across India by March 2029. Future priorities include scaling the Davaindia network with a focus on unit economics, driving operating efficiencies, and enhancing profitability.
